Update 2020: Management of Non-Small Cell Lung Cancer.
Alexander M, Kim SY, Cheng H.
Lung. 2020 Dec;198(6):897-907. doi: 10.1007/s00408-020-00407-5. Epub 2020 Nov 11.
Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.
Jonna S, Subramaniam DS.
Discov Med. 2019 Mar;27(148):167-170.
The biology and management of non-small cell lung cancer.
Herbst RS, Morgensztern D, Boshoff C.
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.
New promises and challenges in the treatment of advanced non-small-cell lung cancer.
Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, Jänne PA, Peters S, Hirsch FR.
Lancet. 2024 Aug 24;404(10454):803-822. doi: 10.1016/S0140-6736(24)01029-8. Epub 2024 Aug 6.
Emerging Targets in Non-Small Cell Lung Cancer.
Liu L, Soler J, Reckamp KL, Sankar K.
Int J Mol Sci. 2024 Sep 18;25(18):10046. doi: 10.3390/ijms251810046.
SMARCA4: Current status and future perspectives in non-small-cell lung cancer.
Tian Y, Xu L, Li X, Li H, Zhao M.
Cancer Lett. 2023 Feb 1;554:216022. doi: 10.1016/j.canlet.2022.216022. Epub 2022 Nov 28.
Update 2025: Management of Non-Small-Cell Lung Cancer.
Jeon H, Wang S, Song J, Gill H, Cheng H.
Lung. 2025 Mar 25;203(1):53. doi: 10.1007/s00408-025-00801-x.
Abandoning the Notion of Non-Small Cell Lung Cancer.
Relli V, Trerotola M, Guerra E, Alberti S.
Trends Mol Med. 2019 Jul;25(7):585-594. doi: 10.1016/j.molmed.2019.04.012. Epub 2019 May 30.
Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives.
Imyanitov EN, Iyevleva AG, Levchenko EV.
Crit Rev Oncol Hematol. 2021 Jan;157:103194. doi: 10.1016/j.critrevonc.2020.103194. Epub 2020 Dec 11.
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer.
Nagano T, Tachihara M, Nishimura Y.
Curr Cancer Drug Targets. 2019;19(8):595-630. doi: 10.2174/1568009619666181210114559.
